YANG Hui, CHEN Li, ZHANG Feng -xue, et al. Role and Mechanism of Modified Sini Decoction Against Immunological Liver Injury in Mice[J]. Chinese journal of experimental traditional medical formulae, 2014, 20(19): 138-141.
DOI:
YANG Hui, CHEN Li, ZHANG Feng -xue, et al. Role and Mechanism of Modified Sini Decoction Against Immunological Liver Injury in Mice[J]. Chinese journal of experimental traditional medical formulae, 2014, 20(19): 138-141. DOI: 10.13422/j.cnki.syfjx.2014190138.
Role and Mechanism of Modified Sini Decoction Against Immunological Liver Injury in Mice
Objective: To observe protective effect of Modified Sini decoction on immunological liver injury in mice induced by concanavalin A(Con A)and the role of T lymphocyte subsets in which. Method: The mouse were randomly divided into normal saline(NS)group
Con A group
bifendate group(LB
150 mg·kg-1)
Modified Sini decoction low
high dosage group(120
240 mg·kg-1).All groups
except for the NS group
were given Con A aqueous solution(18 mg·kg-1)via tail vein injection 1 hour after drug administration at d1 and d3
peripheral blood was collected 12 h after Con A was injected. The percentage of T lymphocyte subsets CD4+
CD8+cells were detected in plasma by a flow cytometer
using enzyme-linked imunosorbent assay(ELISA) for determination the serum cytokines:interferon-γ(IFN-γ)
tumor necrosis factor alpha(TNF-α)
interleukin(IL)-10 and activities of alanine aminotransferase(ALT)
aspartate aminotransferase(AST). Result: The activity of AST and ALT of Modified Sini decoction treatment groups significantly dropped in mice of Con A-mediated liver injury;SND-treated groups could significantly reduced the liver injury model group had elevated inflammatory cytokines IFN-γ or TNF-α level(P<0.05
P<0.01);Modified Sini decoction groups could improve the liver injury model group had lowed T-cell subsets CD4+
CD8+rate(P<0.05). Conclusion: Modified Sini decoction is effective in protecting immunological liver injury in mice induced by Con A and this mechanism maybe closely associated with its action in regulating the T-cell subsets and in reducing the inflammatory cytokines.
Mechanism of Shaoyaotang in Modulating MDSCs-related Immunosuppressive Microenvironment in Prevention and Treatment of Colitis-associated Carcinogenesis
Tongxie Yaofang Regulates T Lymphocyte Subsets to Improve Immune Microenvironment of Colorectal Cancer Under Chronic Stress
Clinical Observation of Qingre Tiaoxue Decoction Combined with Wuwei Xiaodu Drink in Enema Treatment of Sequelae of Pelvic Inflammatory Disease
Clinical Efficacy of Modified Zhibo Dihuangwan in Treatment of Purpura Nephritis with Deficiency of Liver and Kidney Yin in Children
Clinical Efficacy of Modified Shenling Baizhusan on Stroke-associated Pneumonia with Lung-Qi Deficiency Syndrome
Related Author
CHEN Xue
WANG Chenglei
YANG Bingwei
ZHAI Haoyu
WU Ying
LI Weidong
YANG Yi
HU Yane
Related Institution
Guang'anmen Hospital, China Academy of Chinese Medical Sciences
Shaanxi University of Chinese Medicine
Traditional Chinese Medicine (TCM) Regulating Metabolic Diseases Key Laboratory of Sichuan Province, Hospital of Chengdu University of TCM